Availability of Specific Direct Oral Anticoagulant Reversal Agents in US Hospitals

被引：11
|
作者：
Kanjee, Zahir [1 ,2 ]
McCann, Marissa L. [3 ]
Freed, Jason A. [2 ,4 ]
机构：
[1] Beth Israel Deaconess Med Ctr, Div Gen Med, Boston, MA 02215 USA
[2] Harvard Med Sch, Dept Med, Boston, MA 02115 USA
[3] Beth Israel Deaconess Med Ctr, Dept Pharm, Boston, MA 02215 USA
[4] Beth Israel Deaconess Med Ctr, Div Hematol & Hematol Malignancies, Boston, MA 02215 USA
来源：
JAMA NETWORK OPEN | 2021年 / 4卷 / 05期
关键词：
ATRIAL-FIBRILLATION; MANAGEMENT;
D O I：
10.1001/jamanetworkopen.2021.10079
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Availability of specific DOAC reversal agents varies in US hospitals
    [J]. Reactions Weekly, 2021, 1857 (1) : 5 - 5
  • [2] Direct Oral Anticoagulant Agents: Pharmacologic Profile, Indications, Coagulation Monitoring, and Reversal Agents
    Rose, Deborah K.
    Bar, Barak
    [J]. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2018, 27 (08): : 2049 - 2058
  • [3] Reversal Agents for Oral Anticoagulant Rivaroxaban
    Fattah, Tanzeela Abdul
    Saeed, Aamer
    Lank, Fayaz Ali
    Channar, Pervaiz Ali
    [J]. JOURNAL OF THE CHEMICAL SOCIETY OF PAKISTAN, 2018, 40 (05): : 974 - 983
  • [4] Specific Reversal Agents for Direct Oral Anticoagulants in Acute Stroke
    Frol, Senta
    Oblak, Janja Pretnar
    Sabovic, Miso
    van Zwam, Wim H.
    Ntaios, George
    Lovblad, Karl Olof
    Gruber, Andreas
    Kermer, Pawel
    [J]. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2024, 30
  • [5] Introduction to Direct Oral Anticoagulants and Rationale for Specific Reversal Agents
    Pollack, Charles V., Jr.
    [J]. AMERICAN JOURNAL OF MEDICINE, 2016, 129 (11): : S31 - S32
  • [6] Introduction to direct oral anticoagulants and rationale for specific reversal agents
    Pollack, Charles V., Jr.
    [J]. AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2016, 34 (11): : 1 - 2
  • [7] Specific Antidotes for Direct Oral Anticoagulant Reversal Case Closed or Cold Case?
    Godier, Anne
    Martin, Anne-Celine
    [J]. CIRCULATION, 2019, 140 (18) : 1445 - 1447
  • [8] DIRECT ORAL ANTICOAGULANT REVERSAL IN ONCOLOGY PATIENTS
    Vo, Liza
    Brown, Anne Rain
    Collins, Reagan
    [J]. CRITICAL CARE MEDICINE, 2021, 49 (01) : 456 - 456
  • [9] Overview of direct oral anticoagulant therapy reversal
    Gulseth, Michael R.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2016, 73 (10) : S5 - S13
  • [10] Reversal of anticoagulant effects of edoxaban, an oral, direct factor Xa inhibitor, with haemostatic agents
    Fukuda, Toshio
    Honda, Yuko
    Kamisato, Chikako
    Morishima, Yoshiyuki
    Shibano, Toshiro
    [J]. THROMBOSIS AND HAEMOSTASIS, 2012, 107 (02) : 253 - 259
12345